Docosahexaenoic acid attenuates breast cancer cell metabolism and the Warburg phenotype by targeting bioenergetic function

Molecular Carcinogenesis

Volumn 54, Issue 9, 2015, Pages 810-820

  Mouradian, Michael ^a   Kikawa, Keith D ^a   Dranka, Brian P ^b   Komas, Steven M ^b   Kalyanaraman, Balaraman ^b   Pardini, Ronald S ^a  

^a UNIVERSITY OF NEVADA   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Breast carcinogenesis; Cancer metabolism; Diet; Fatty acids; Prevention

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; DOCOSAHEXAENOIC ACID; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTATE DEHYDROGENASE; LACTIC ACID; THREONINE; ANTINEOPLASTIC ANTIMETABOLITE; GLUCOSE;

AEROBIC METABOLISM; ARTICLE; BIOENERGY; BREAST CANCER CELL LINE; BT 474 CELL LINE; CANCER CELL LINE; CANCER GROWTH; CANCER PREVENTION; CANCER SURVIVAL; CELL METABOLISM; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG TARGETING; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; HUMAN CELL; MCF 10A CELL LINE; MDA MB 231 CELL LINE; METABOLIC STRESS; NON-TRANSFORMED CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; BREAST; BREAST NEOPLASMS; DRUG EFFECTS; ENERGY METABOLISM; FEMALE; METABOLISM; TUMOR CELL LINE;

ANIMALIA;

ADENOSINE TRIPHOSPHATE; ANTIMETABOLITES, ANTINEOPLASTIC; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; DOCOSAHEXAENOIC ACIDS; ENERGY METABOLISM; FEMALE; GLUCOSE; GLYCOLYSIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT;

EID: 84938965067     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22151     Document Type: Article

References (53)

1. American Cancer Society. Cancer Facts & Figures 2013. Atlanta Am Cancer Soc 2013; 1-60.
2. Zhao Y, Liu H, Riker AI, et al. Emerging metabolic targets in cancer therapy. Front Biosci J Virt Libr 2011; 16:1844-1860.
3. Ward C, Langdon SP, Mullen P, et al. New strategies for targeting the hypoxic tumour microenvironment in breast cancer. Cancer Treat Rev 2013; 39:171-179.
4. Warburg O. On the origin of cancer cells. Am Assoc Adv Sci 1956; 123:309-314.
5. Estrella V, Chen T, Lloyd M, et al. Acidity generated by the tumor microenvironment drives local invasion. Cancer Res 2013; 73:1524-1535.
6. Zhong H, Marzo A, De Laughner E, Lim M. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 1999; 59:5830-5835.
7. Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell 2012; 148:399-408.
8. Semenza GL. Molecular mechanisms mediating metastasis of hypoxic breast cancer cells. Trends Mol Med 2012; 18:534-543.
9. Semenza GL. HIF-1: Upstream and downstream of cancer metabolism. Curr Opin Genet Dev 2010; 20:51-56.
10. Bos R, van der Groep P, Greijer AE, et al. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 2003; 97:1573-1581.
11. Giatromanolaki A, Koukourakis MI, Simopoulos C, et al. c-erbB-2 related aggressiveness in breast cancer is hypoxia inducible factor-1alpha dependent. Cancer Res 2004; 10:7972-7977.
12. Dales J-P, Garcia S, Meunier-Carpentier S, et al. Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: Retrospective study in a series of 745 patients. Int J Cancer 2005; 116:734-739.
13. Pelicano H, Martin DS, Xu R-H, Huang P. Glycolysis inhibition for anticancer treatment. Oncogene 2006; 25:4633-4646.
14. Calder PC. Mechanisms of action of (n-3) fatty acids. J Nutr 2012; 142:592S-599S.
15. Tuller ER, Brock AL, Yu H, Lou JR, Benbrook DM, Ding W-Q. PPARalpha signaling mediates the synergistic cytotoxicity of clioquinol and docosahexaenoic acid in human cancer cells. Biochem Pharmacol 2009; 77:1480-1486.
16. Edwards IJ, O'Flaherty JT. Omega-3 fatty acids and PPARgamma in cancer. PPAR Res 2008; 2008:1-14.
17. Kliewer SA, Sundseth SS, Jones SA, et al. Fatty acids, eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha, gamma. Proc Natl Acad Sci U S.A 1997; 94:4318-4323.
18. Xu HE, Lambert MH, Montana VG, et al. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell 1999; 3:397-403.
19. Thoennes SR, Tate PL, Price TM, Kilgore MW. Differential transcriptional activation of peroxisome proliferator-activated receptor gamma by omega-3 and omega-6 fatty acids in MCF-7 cells. Mol Cell Endocrinol 2000; 160:67-73.
20. Tuller ER, Beavers CT, Lou JR, Ihnat MA, Benbrook DM. Docosahexaenoic acid inhibits superoxide dismutase 1 gene transcription in human cancer cells: The involvement of peroxisome proliferator-activated receptor alpha and hypoxia-inducible factor-2alpha signaling. Mol Pharmacol 2009; 76:588-595.
21. Schoonjans K, Peinado-onsurbe J, Lefebvre A, et al. PPARa, PPARy activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO.J 1996; 15:5336-5348.
22. Zapata-Gonzalez F, Rueda F, Petriz J, et al. Human dendritic cell activities are modulated by the omega-3 fatty acid, docosahexaenoic acid, mainly through PPAR(gamma):RXR heterodimers: Comparison with other polyunsaturated fatty acids. J Leukoc Biol 2008; 84:1172-1182.
23. Calviello G, Di Nicuolo F, Gragnoli S, et al. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1α induction pathway. Carcinogenesis 2004; 25:2303-2310.
24. Zhou J, Zhang S, Xue J, et al. Activation of peroxisome proliferator-activated receptor α (PPARα) suppresses hypoxia-inducible factor-1α (HIF-1α) signaling in cancer cells. J Biol Chem 2012; 287:35161-35169.
25. Dranka BP, Benavides Ga, Diers AR, et al. Assessing bioenergetic function in response to oxidative stress by metabolic profiling. Free Radic Biol Med 2011; 51:1621-1635.
26. Cheng G, Zielonka J, Dranka BP, et al. Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death. Cancer Res 2012; 72:2634-2644.
27. Rogers KR, Kikawa KD, Mouradian M, et al. Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft association. Carcinogenesis 2010; 31:1523-1530.
28. Fan Y, Dickman KG, Zong W-X. Akt and c-Myc differentially activate cellular metabolic programs and prime cells to bioenergetic inhibition. J Biol Chem 2010; 285:7324-7333.
29. Liang Y, Buettger C, Berner DK, Matschinsky FM. Chronic effect of fatty acids on insulin release is not through the alteration of glucose metabolism in a pancreatic beta-cell line (beta HC9). Diabetologia 1997; 40:1018-1027.
30. Vander Heiden M, Plas D, Rathmell J, Fox C, Harris M, Thompson C. Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol Cell Biol 2001; 21:5899-5912.
31. Ashcroft S, Weerasinghe L, Bassett J, Randle P. The pentose cycle and insulin release in mouse pancreatic islets. Biochem J 1972; 126:525-532.
32. Oba M. Baldwin R 4th, Bequette B. Oxidation of glucose, glutamate, and glutamine by isolated ovine enterocytes in vitro is decreased by the presence of other metabolic fuels. J Anim Sci 2004; 82:479-486.
33. Fan Y-Y, Ran Q, Toyokuni S, et al. Dietary fish oil promotes colonic apoptosis and mitochondrial proton leak in oxidatively stressed mice. Cancer Prev Res 2011; 4:1267-1274.
34. Dranka BP, Hill BG, Darley-Usmar VM. Mitochondrial reserve capacity in endothelial cells: The impact of nitric oxide and reactive oxygen species. Free Radic Biol Med 2010; 48:905-914.
35. Welsch C. Relationship between dietary fat and experimental mammary tumorigenesis: A review and critique. Cancer Res 1992; 52:2040-2048.
36. Mouradian M, Kikawa KD, Johnson ED, Beck KL, Pardini RS. Key roles for GRB2-associated-binding protein 1, phosphatidylinositol-3-kinase, cyclooxygenase 2, prostaglandin E2 and transforming growth factor alpha in linoleic acid-induced upregulation of lung and breast cancer cell growth. Prostaglandins Leukot Essent Fatty Acids 2014; 90:105-115.
37. Rose D. Dietary fat, fatty acids and breast cancer. Breast Cancer 1997; 4:7-16.
38. Hu C, Wang L, Chodosh L, Keith B, Simon M. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 2003; 23:9361-9374.
39. Zhdanov AV, Dmitriev RI, Golubeva AV, Gavrilova Sa, Papkovsky DB. Chronic hypoxia leads to a glycolytic phenotype and suppressed HIF-2 signaling in PC12 cells. Biochim Biophys Acta 2013; 1830:3553-3569.
40. Robey IF, Lien AD, Welsh SJ, Baggett BK, Gillies RJ. Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors. Neoplasia 2005; 7:324-330.
41. Beasley N, Leek R, Alam M, Turley H. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: Relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res 2002; 62:2493-2497.
42. Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. Dietary long-chain n-3 fatty acids for the prevention of cancer: A review of potential mechanisms. Am J Clin Nutr 2004; 79:935-945.
43. Kikawa KD, Herrick JS, Tateo RE, Mouradian M, Tay JS, Pardini RS. Induced oxidative stress and cell death in the A549 lung adenocarcinoma cell line by ionizing radiation is enhanced by supplementation with docosahexaenoic acid. Nutr Cancer 2010; 62:1017-1024.
44. Stanley WC, Khairallah RJ, Dabkowski ER. Update on lipids and mitochondrial function: Impact of dietary n-3 polyunsaturated fatty acids. Curr Opin Clin Nutr Metab Care 2012; 15:122-126.
45. Watkins SM, Carter LC, German JB. Docosahexaenoic acid accumulates in cardiolipin and enhances HT-29 cell oxidant production. J Lipid Res 1998; 39:1583-1588.
46. Lee M, Bae M-A. Docosahexaenoic acid induces apoptosis in CYP2E1-containing HepG2 cells by activating the c-Jun N-terminal protein kinase related mitochondrial damage. J Nutr Biochem 2007; 18:348-354.
47. Giros A, Grzybowski M, Sohn VR, et al. Regulation of colorectal cancer cell apoptosis by the n-3 polyunsaturated fatty acids Docosahexaenoic and Eicosapentaenoic. Cancer Prev Res 2009; 2:732-742.
48. Stravopodis DJ, Margaritis LH, Voustinas GE. Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex. Curr Med Chem 2007; 14:3122-3138.
49. Peng X, Guo X, Borkan SC, et al. Heat shock protein 90 stabilization of ErbB2 expression is disrupted by ATP depletion in myocytes. J Biol Chem 2005; 280:13148-13152.
50. Crabtree H. The carbohydrate metabolism of certain pathological overgrowths. Biochem J 1928; 22:8-11.
51. Pardini RS. Nutritional intervention with omega-3 fatty acids enhances tumor response to anti-neoplastic agents. Chem Biol Interact 2006; 162:89-105.
52. Hardie DG. The AMP-activated protein kinase pathway-new players upstream and downstream. J Cell Sci 2004; 117:5479-5487.
53. Jing K, Song K-S, Shin S, et al. Docosahexaenoic acid induces autophagy through p53/AMPK/mTOR signaling and promotes apoptosis in human cancer cells harboring wild-type p53. Autophagy 2011; 7:1348-1358.